Detalhe da pesquisa
1.
Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
J Immunol
; 196(3): 1400-11, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26746188
2.
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.
Blood
; 124(5): 812-21, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855210
3.
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.
Blood
; 121(14): 2678-88, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23325834
4.
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.
Blood
; 116(19): 3853-64, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696944
5.
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.
Blood
; 115(13): 2686-94, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20097883
6.
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Bone Marrow Transplant
; 57(5): 753-759, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210563
7.
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis.
EJHaem
; 3(4): 1277-1286, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467849
8.
Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.
J Immunol
; 181(9): 6010-9, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941190
9.
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.
Clin Cancer Res
; 24(8): 1834-1844, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444931
10.
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.
Front Immunol
; 6: 202, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972872
11.
Harnessing adaptive natural killer cells in cancer immunotherapy.
Mol Oncol
; 9(10): 1904-17, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604011